Update on the management of neuromuscular block: focus on sugammadex

References

• ArbousMSMeursingAEEvan KleefJW2005Impact of anesthesia management characteristics on severe morbidity and mortalityAnesthesiology1022576815681938
   PubMed Web of Science ®Google Scholar
• BomABradleyMCameronK2002A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic hostAngew Chem Int Ed Engl412667012491405
   PubMed Web of Science ®Google Scholar
• BomAMasonRHopeFvan EgmondJMuirA2001The cyclodextrin derivative Org 25969, which forms complexes with steroidal neuromuscular blocking agents, causes selective reversal of normal and profound neuromuscular blockAnesthesiology95A1020
   Google Scholar
• BomAHvan EgmondJHopeF2003Rapid reversal of rocuronium-induced neuromuscular block by Org 25969 is independent of renal perfusionAnesthesiology99A1158
   Google Scholar
• BooijLHDJDe BoerHDVan EgmondJ2002Reversal agents for non-depolarizing neuromuscular blockade: reasons for and development of a new conceptSemin Anesth Periop Med Pain21928
   Google Scholar
• ChallaRAhujaAAliJ2005Cyclodextrins in drug delivery: an updated reviewAAPS PharmSciTech632957
   PubMed Web of Science ®Google Scholar
• de BoerHDMarcusMSchoutenP2005Reversal of rocuronium-induced (1.2 mg/kg) neuromuscular block by Org 25969: a multi-center dose finding and safety studyAnesthesiology103A1117
   Google Scholar
• de BoerHDvan EgmondJvan de PolF2006aChemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeysBr J Anaesth96201616377646
   PubMed Web of Science ®Google Scholar
• de BoerHDvan EgmondJvan de PolF2006bReversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized Rhesus monkeysAnesthesiology1047182316571967
   PubMed Web of Science ®Google Scholar
• EpemoluOBomAHopeF2003Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969Anesthesiology99632712960547
   PubMed Web of Science ®Google Scholar
• EpemoluOMayerIHopeF2002Liquid chromatography/mass spectrometric bioanalysis of a modified γ cyclodextrin (Org 25969) and rocuronium bromide (Org 9426) in guinea pig plasma and urine: its application to determine the plasma pharmacokinetics of Org 25969Rapid Commun Mass Spectrom1619465212362386
   PubMed Web of Science ®Google Scholar
• GijsenberghFRamaelSHouwingN2005First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromideAnesthesiology10369570316192761
   PubMed Web of Science ®Google Scholar
• HopeFBomA2001Org 25969 reverses rocuronium-induced neuromuscular blockade in the cat without important hemodynamic effectsEur J Anaesthesiol18Suppl 2310011270018
   PubMed Web of Science ®Google Scholar
• HunterJM1995New neuromuscular blocking drugsN Engl J Med332169197760871
   PubMed Web of Science ®Google Scholar
• Khunl-BradyKRexCKjaerCC2005Reversal of high dose rocuronium with Org 25969Eur J Anaesthesiol22Suppl 34121
   Google Scholar
• MasonRBomA2001Org 25969 causes selective reversal of neuromuscular block induced by steroidal NMBs in anaesthetized guinea pigsEur J Anaesthesiol18Suppl 2310011270018
   PubMed Web of Science ®Google Scholar
• MasonRBomAMcIndewarI2002Org 25969 causes rapid reversal of rocuronium-induced neuromuscular block, independent of acid-base statusEur J AnaesthesiolA-1009
   Web of Science ®Google Scholar
• MenckeTEchternachMKleinschmidtS2003Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trialAnesthesiology9810495612717124
   PubMed Web of Science ®Google Scholar
• MillerSBomA2001Org 25969 causes selective reversal of neuromuscular blockade induced by steroidal NMBs in the mouse hemi-diaphragm preparationEur J Anaesthesiol18Suppl 2310011270018
   PubMed Web of Science ®Google Scholar
• OsmerCVogeleCZickmanB1996Comparative use of muscle relaxants and their reversal in three European countries: a survey in France, Germany and Great BritainEur J Anaesthesiol13389998842663
   PubMed Web of Science ®Google Scholar
• PedersenTViby-MogensenJRingstedC1992Anaesthetic practice and postoperative pulmonary complicationsActa Anaesthesiol Scand36812181466220
   PubMed Web of Science ®Google Scholar
• RexCKhunl-BradyKSielenkaemperA2005Reversal of high dose rocuronium (1.2 mg/kg) with Org 25969Anesthesiology103A1129
   Google Scholar
• SacanOKleinKWhitePF2006Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparision wth neostigmine-glycopyrrolate and edrophonium-atropineEur J Anaesthesiol23Suppl 37143
   Google Scholar
• ShieldsMMirakhurRKMoppettI2006Org 25969 (sugamadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular blockBr J Anaesth96364316357116
   PubMed Web of Science ®Google Scholar
• ShortenGD1993Postoperative residual curarisation: incidence, aetiology and associated morbidityAnaesth Intensive Care2178298122734
   PubMed Web of Science ®Google Scholar
• SorgenfreiIFNorrildKLarsenPB2006Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety studyAnesthesiology1046677416571960
   PubMed Web of Science ®Google Scholar
• SuyKMoriasKHansP2007Fast, effective and safe reversal of rocuronium and vecuronium-induced moderate neuromuscular block by the selective relaxant binding agent Org 25969Anesthesiology106283817264722
   PubMed Web of Science ®Google Scholar
• VanackerBVermeyenKStruysMRF2005Reversal by Org 25969 is not affected by sevoflurane when compared with propofolEur J Anaesthesiol22Suppl 34119
   Google Scholar
• Van VlymenJMParlowJL1997The effects of reversal of neuromuscular blockade on autonomic control in the perioperative periodAnesth Analg84148548989016
   PubMed Web of Science ®Google Scholar
• ZhangMQ2003Drug-specific cyclodextrins: the future of rapid neuromuscular block reversalDrugs Future234754
   Web of Science ®Google Scholar